PCMT1 Is a Potential Prognostic Biomarker and Is Correlated with Immune Infiltrates in Breast Cancer

Figure 3

(a) Analysis of pancancer mutations of PCMT1. (b) Analysis of PCMT1 mutations in breast cancer. (c) Correlation between PCMT1 and the abundance of immune infiltration in breast cancer. (d) Correlation between PCMT1 and TMB. (e) Correlation between PCMT1 and MSI. (f) The relationship between PCMT1 expression level and ICB response.

(a)

(b)

(c)

(d)

(e)

(f)